Annual CFI
-$19.13 M
-$26.23 M-369.21%
December 31, 2023
Summary
- As of February 7, 2025, PBYI annual cash flow from investing activities is -$19.13 million, with the most recent change of -$26.23 million (-369.21%) on December 31, 2023.
- During the last 3 years, PBYI annual CFI has fallen by -$52.53 million (-157.26%).
- PBYI annual CFI is now -113.45% below its all-time high of $142.19 million, reached on December 31, 2016.
Performance
PBYI Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$259.00 K
-$444.00 K-63.16%
September 30, 2024
Summary
- As of February 7, 2025, PBYI quarterly cash flow from investing activities is $259.00 thousand, with the most recent change of -$444.00 thousand (-63.16%) on September 30, 2024.
- Over the past year, PBYI quarterly CFI has dropped by -$10.92 million (-97.68%).
- PBYI quarterly CFI is now -99.68% below its all-time high of $81.46 million, reached on March 31, 2016.
Performance
PBYI Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$26.29 M
-$10.92 M-71.05%
September 30, 2024
Summary
- As of February 7, 2025, PBYI TTM cash flow from investing activities is -$26.29 million, with the most recent change of -$10.92 million (-71.05%) on September 30, 2024.
- Over the past year, PBYI TTM CFI has dropped by -$3.46 million (-15.16%).
- PBYI TTM CFI is now -116.32% below its all-time high of $161.03 million, reached on September 30, 2016.
Performance
PBYI TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
PBYI Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -369.2% | -97.7% | -15.2% |
| 3 y3 years | -157.3% | -87.0% | -336.2% |
| 5 y5 years | +66.8% | -87.0% | -336.2% |
PBYI Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -369.2% | at low | -97.7% | +101.4% | -211.4% | at low |
| 5 y | 5-year | -157.3% | at low | -99.3% | +101.4% | -131.3% | at low |
| alltime | all time | -113.5% | +77.7% | -99.7% | +100.3% | -116.3% | +78.8% |
Puma Biotechnology Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $259.00 K(-63.2%) | -$26.29 M(+71.0%) |
| Jun 2024 | - | $703.00 K(-103.7%) | -$15.37 M(-26.0%) |
| Mar 2024 | - | -$19.08 M(+133.5%) | -$20.75 M(+8.5%) |
| Dec 2023 | -$19.13 M(-369.2%) | -$8.17 M(-173.1%) | -$19.13 M(-16.2%) |
| Sep 2023 | - | $11.18 M(-338.7%) | -$22.83 M(-12.2%) |
| Jun 2023 | - | -$4.68 M(-73.2%) | -$26.01 M(+34.6%) |
| Mar 2023 | - | -$17.45 M(+47.0%) | -$19.33 M(-372.1%) |
| Dec 2022 | $7.10 M(-165.3%) | -$11.87 M(-248.4%) | $7.10 M(-69.9%) |
| Sep 2022 | - | $8.00 M(+300.5%) | $23.60 M(+112.0%) |
| Jun 2022 | - | $2.00 M(-77.8%) | $11.13 M(+227.2%) |
| Mar 2022 | - | $8.98 M(+94.4%) | $3.40 M(-131.3%) |
| Dec 2021 | -$10.88 M(-132.6%) | $4.62 M(-203.4%) | -$10.88 M(+132.5%) |
| Sep 2021 | - | -$4.47 M(-22.0%) | -$4.68 M(+67.9%) |
| Jun 2021 | - | -$5.73 M(+8.1%) | -$2.79 M(-55.6%) |
| Mar 2021 | - | -$5.30 M(-149.0%) | -$6.28 M(-118.8%) |
| Dec 2020 | $33.40 M(+547.0%) | $10.82 M(-519.8%) | $33.40 M(+50.8%) |
| Sep 2020 | - | -$2.58 M(-72.0%) | $22.15 M(-65.2%) |
| Jun 2020 | - | -$9.22 M(-126.8%) | $63.70 M(-24.3%) |
| Mar 2020 | - | $34.38 M(-8057.6%) | $84.12 M(+1529.3%) |
| Dec 2019 | $5.16 M(-109.0%) | -$432.00 K(-101.1%) | $5.16 M(-36.9%) |
| Sep 2019 | - | $38.97 M(+247.8%) | $8.18 M(-115.7%) |
| Jun 2019 | - | $11.21 M(-125.1%) | -$52.16 M(-49.0%) |
| Mar 2019 | - | -$44.58 M(-1826.7%) | -$102.17 M(+77.3%) |
| Dec 2018 | -$57.62 M(+273.3%) | $2.58 M(-112.1%) | -$57.62 M(-31.2%) |
| Sep 2018 | - | -$21.36 M(-45.0%) | -$83.72 M(+357.8%) |
| Jun 2018 | - | -$38.80 M(>+9900.0%) | -$18.29 M(-147.4%) |
| Mar 2018 | - | -$40.00 K(-99.8%) | $38.60 M(-350.0%) |
| Dec 2017 | -$15.44 M(-110.9%) | -$23.52 M(-153.4%) | -$15.44 M(-153.4%) |
| Sep 2017 | - | $44.08 M(+143.8%) | $28.92 M(+102.1%) |
| Jun 2017 | - | $18.08 M(-133.4%) | $14.31 M(+114.9%) |
| Mar 2017 | - | -$54.07 M(-359.5%) | $6.66 M(-95.3%) |
| Dec 2016 | $142.19 M | $20.84 M(-29.3%) | $142.19 M(-11.7%) |
| Sep 2016 | - | $29.47 M(+182.6%) | $161.03 M(+27.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2016 | - | $10.43 M(-87.2%) | $126.82 M(+162.7%) |
| Mar 2016 | - | $81.46 M(+105.3%) | $48.28 M(-156.2%) |
| Dec 2015 | -$85.86 M(+35.7%) | $39.68 M(-936.1%) | -$85.86 M(-16.9%) |
| Sep 2015 | - | -$4.75 M(-93.0%) | -$103.34 M(+1.9%) |
| Jun 2015 | - | -$68.12 M(+29.3%) | -$101.37 M(-18.2%) |
| Mar 2015 | - | -$52.68 M(-337.3%) | -$123.90 M(+95.8%) |
| Dec 2014 | -$63.27 M(+52.4%) | $22.20 M(-901.3%) | -$63.27 M(-23.0%) |
| Sep 2014 | - | -$2.77 M(-96.9%) | -$82.19 M(+6.5%) |
| Jun 2014 | - | -$90.65 M(-1241.3%) | -$77.19 M(+1123.5%) |
| Mar 2014 | - | $7.94 M(+141.2%) | -$6.31 M(-84.8%) |
| Dec 2013 | -$41.53 M(+3301.4%) | $3.29 M(+47.9%) | -$41.53 M(-8.1%) |
| Sep 2013 | - | $2.23 M(-111.3%) | -$45.21 M(-4.7%) |
| Jun 2013 | - | -$19.77 M(-27.5%) | -$47.45 M(+69.0%) |
| Mar 2013 | - | -$27.28 M(+6912.6%) | -$28.08 M(+2199.4%) |
| Dec 2012 | -$1.22 M(-30.1%) | -$389.00 K(+3436.4%) | -$1.22 M(-52.6%) |
| Sep 2012 | - | -$11.00 K(-97.2%) | -$2.57 M(+0.4%) |
| Jun 2012 | - | -$397.00 K(-6.4%) | -$2.56 M(+18.1%) |
| Mar 2012 | - | -$424.00 K(-75.7%) | -$2.17 M(+24.3%) |
| Dec 2011 | -$1.75 M(<-9900.0%) | -$1.74 M(<-9900.0%) | -$1.75 M(>+9900.0%) |
| Sep 2011 | - | $0.00(-100.0%) | -$3400.00(0.0%) |
| Jun 2011 | - | -$3400.00(<-9900.0%) | -$3400.00(<-9900.0%) |
| Mar 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2008 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2008 | - | $0.00 | $0.00 |
FAQ
- What is Puma Biotechnology annual cash flow from investing activities?
- What is the all time high annual CFI for Puma Biotechnology?
- What is Puma Biotechnology annual CFI year-on-year change?
- What is Puma Biotechnology quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Puma Biotechnology?
- What is Puma Biotechnology quarterly CFI year-on-year change?
- What is Puma Biotechnology TTM cash flow from investing activities?
- What is the all time high TTM CFI for Puma Biotechnology?
- What is Puma Biotechnology TTM CFI year-on-year change?
What is Puma Biotechnology annual cash flow from investing activities?
The current annual CFI of PBYI is -$19.13 M
What is the all time high annual CFI for Puma Biotechnology?
Puma Biotechnology all-time high annual cash flow from investing activities is $142.19 M
What is Puma Biotechnology annual CFI year-on-year change?
Over the past year, PBYI annual cash flow from investing activities has changed by -$26.23 M (-369.21%)
What is Puma Biotechnology quarterly cash flow from investing activities?
The current quarterly CFI of PBYI is $259.00 K
What is the all time high quarterly CFI for Puma Biotechnology?
Puma Biotechnology all-time high quarterly cash flow from investing activities is $81.46 M
What is Puma Biotechnology quarterly CFI year-on-year change?
Over the past year, PBYI quarterly cash flow from investing activities has changed by -$10.92 M (-97.68%)
What is Puma Biotechnology TTM cash flow from investing activities?
The current TTM CFI of PBYI is -$26.29 M
What is the all time high TTM CFI for Puma Biotechnology?
Puma Biotechnology all-time high TTM cash flow from investing activities is $161.03 M
What is Puma Biotechnology TTM CFI year-on-year change?
Over the past year, PBYI TTM cash flow from investing activities has changed by -$3.46 M (-15.16%)